MIF Signaling Pathway as a Pathogenic Driver and Potential Target in Pancreatic Cancer

NCI ’ s Center for Cancer Research (CCR) Grand Rounds Dr. Hussain is a Tenure Track investigator in the Laboratory of Human Carcinogenesis, CCR, NCI. He received his Ph.D. degree in Cancer Biology from Jawaharlal Nehru University, New Delhi, India. Dr. Hussain received his post-doctoral training at the Swiss Institute for Cancer Research (ISREC), Lausanne, Switzerland, and the Laboratory of Human Carcinogenesis, CCR and then worked as a Clinical Instructor at the University of Maryland School of Medicine in Baltimore. He was appointed as a Tenure Track investigator at the Laboratory of Human Carcinogenesis in 2009. Dr. Hussain ’ s research program investigates the underlying mechanisms of pancreatic cancer progression and disease aggressiveness with a focus on the role of inflammatory mediators to identify novel therapeutic targets. Dr. Hussain ’ s group has recently provided proof-of-concept that macrophage migration inhibitory factor and inducible nitric oxide synthase are candidate therapeutic targets for pancreatic cancer.Air date: 6/16/2017 12:00:00 PM
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video